Search
Descriptor English: Anticholinergic Syndrome
Descriptor Spanish: Síndrome Anticolinérgico
Descriptor síndrome anticolinérgico
Scope note: Efectos adversos asociados con drogas ANTICOLINÉRGICAS. Los síntomas clínicos incluyen: TAQUICARDIA, HIPERTERMIA, MIDRIASIS, sequedad de piel y mucosas, disminución de ruidos intestinales y retención urinaria en el síndrome anticolinérgico periférico, así como ALUCINACIONES, PSICOSIS, ATAQUES y COMA en el síndrome anticolinérgico central.
Descriptor Portuguese: Síndrome Anticolinérgica
Descriptor French: Syndrome anticholinergique
Entry term(s): Anticholinergic Syndrome, Central
Anticholinergic Syndrome, Peripheral
Anticholinergic Syndromes
Anticholinergic Syndromes, Central
Anticholinergic Syndromes, Peripheral
Central Anticholinergic Syndrome
Central Anticholinergic Syndromes
Peripheral Anticholinergic Syndrome
Peripheral Anticholinergic Syndromes
Syndrome, Anticholinergic
Syndrome, Central Anticholinergic
Syndrome, Peripheral Anticholinergic
Syndromes, Anticholinergic
Syndromes, Central Anticholinergic
Syndromes, Peripheral Anticholinergic
Tree number(s): C25.100.311
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D064807
Scope note: Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.
Allowable Qualifiers: BL blood
CF cerebrospinal fluid
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
DT drug therapy
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SU surgery
TH therapy
UR urine
VE veterinary
VI virology
Previous Indexing: Cholinergic Antagonists (1995-2013)
Public MeSH Note: 2014
History Note: 2014
Related: Cholinergic Antagonists MeSH
DeCS ID: 55226
Unique ID: D064807
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2014/01/01
Date of Entry: 2013/07/08
Anticholinergic Syndrome - Preferred
Concept UI M0584238
Scope note Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.
Preferred term Anticholinergic Syndrome
Entry term(s) Anticholinergic Syndromes
Syndrome, Anticholinergic
Syndromes, Anticholinergic
Peripheral Anticholinergic Syndrome - Narrower
Concept UI M0584240
Preferred term Peripheral Anticholinergic Syndrome
Entry term(s) Anticholinergic Syndrome, Peripheral
Anticholinergic Syndromes, Peripheral
Peripheral Anticholinergic Syndromes
Syndrome, Peripheral Anticholinergic
Syndromes, Peripheral Anticholinergic
Central Anticholinergic Syndrome - Narrower
Concept UI M0584239
Preferred term Central Anticholinergic Syndrome
Entry term(s) Anticholinergic Syndrome, Central
Anticholinergic Syndromes, Central
Central Anticholinergic Syndromes
Syndrome, Central Anticholinergic
Syndromes, Central Anticholinergic



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey